Patents by Inventor Andrew M. Altman

Andrew M. Altman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reparative cell isolation and delivery
    Patent number: 11369716
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: June 28, 2022
    Assignees: INGENERON, INC., Board of Regents, The University of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Reparative Cell Isolation and Delivery
    Publication number: 20190175787
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Application
    Filed: February 21, 2019
    Publication date: June 13, 2019
    Applicants: Board of Regents, The University of Texas System, Ingeneron, Inc.
    Inventors: Andrew M. Altman, Eckhard U. Alt, Michael E. Coleman
  • Reparative cell isolation and delivery
    Patent number: 10238770
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: March 26, 2019
    Assignees: Ingeneron, Inc., Board of Regents, The university of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Reparative Cell Isolation and Delviery
    Publication number: 20160051729
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Application
    Filed: November 2, 2015
    Publication date: February 25, 2016
    Applicants: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Reparative cell delivery via hyaluronic acid vehicles
    Patent number: 9173975
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: November 3, 2015
    Assignees: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Andrew M. Altman, Eckhard U. Alt, Michael E. Coleman
  • REPARATIVE CELL DELIVERY VIA HYALURONIC ACID VEHICLES
    Publication number: 20110070281
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of case, which include isolated cell populations that are enriched with stem cells and are mixed with hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Application
    Filed: April 23, 2010
    Publication date: March 24, 2011
    Inventors: Andrew M. Altman, Eckhard U. Alt, Michael E. Coleman